Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - A protective role for HDL phospholipids

Advances in Experimental Medicine and Biology

Volumn 660, Issue , 2010, Pages 153-166

  Efrat, Michal ^a   Aviram, Michael ^a  

^a NONE

Author keywords

Antioxidants; Atherosclerosis; Di oleoyl phosphatidylcholine (PC 18:1); HDL; Macrophages; Olive oil; Paraoxonase 1; Phospholipids

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; GLUCONOLACTONASE; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BINDING SITE; CHOLESTEROL TRANSPORT; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME STABILITY; HEART PROTECTION; HUMAN; INTERNALIZATION; LIPID COMPOSITION; LIPID OXIDATION; LIPID STORAGE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; BINDING SITES; CHOLESTEROL; HUMANS; INFLAMMATION; LIPOPROTEINS, HDL; MACROPHAGES; MICE; PHOSPHOLIPIDS; PLANT OILS;

EID: 78649828900     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-350-3_14     Document Type: Article

References (79)

1. Assmann G and Nofer JR (2003) Atheroprotective effects of high-density lipoproteins. Annu Rev Med 54:321-341 (Pubitemid 37386400)
2. Aviram M. (1993) Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis98:1-9. (Pubitemid 23010418)
3. Aviram M (1996) Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Eur J Clin Chem Clin Biochem 34:599-608. (Pubitemid 26293746)
4. Aviram M, Hardak E, Vaya J et al. (2000) Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 101:2510-2517. (Pubitemid 30366256)
5. Aviram M, Rosenblat M (2004) Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37:1304-1316. (Pubitemid 39349234)
6. Aviram M, Rosenblat M, Bisgaier C et al. (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for Paraoxonase. J Clin Invest 101:1581-1590. (Pubitemid 28198486)
7. BoemiM, Leviev I, Sirolla C et al. (2001) Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives: influence on the ability of HDL to protect LDL from oxidation. Atherosclerosis 155:229-235 (Pubitemid 32167144)
8. Braunwald EShattuck Lecture (1997) Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360-1369.
9. Breslow JL (1997) Cardiovascular disease burden increases, NIH funding decreases. Nat Med 3:600-601. (Pubitemid 27264961)
10. Castro GR, Fielding CJ. (1988) Early incorporation of cell derived cholesterol into pre-betamigrating high-density lipoprotein. Biochemistry 27: 25-29. (Pubitemid 18036281)
11. Davidson WS, Lund-Katz S, Johnson WJ et al. (1994) The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J Biol Chem 269: 22975-22982. (Pubitemid 24283274)
12. W. J. de Villiers, E. J. Smart (1999) Macrophage scavenger receptors and foam cell formation J Leukoc Biol 66:740-746. (Pubitemid 29532033)
13. Deakin S, Leviev I, Gomaraschi M et al. (2002) Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem 277:4301-4308. (Pubitemid 34968695)
14. Efrat M, Aviram M (2008) Macrophage paraoxonase 1 (PON1) binding sites. Biochem Biophys Res Commun 376:105-110.
15. Efrat M, Rosenblat M, Mahmood S et al. (2008) Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: In vitro and in vivo studies. Atherosclerosis. [Epub ahead of print]
16. Esteva O, Baudet MF, Lasserre M et al. (1986) Influence of the fatty acid composition of highdensity lipoprotein phospholipids on the cholesterol efflux from cultured fibroblasts. Biochim Biophys Acta 875:174-182. (Pubitemid 16149039)
17. Faggiotto A, Ross R. (1984) Studies of hypercholesterolemia in the nonhuman primate, I: changes that lead to fatty streak formation. Arteriosclerosis 4:323-340. (Pubitemid 14092676)
18. Fowler S, Shio H, Haley NJ (1979) Characterization of lipid-laden aortic cells from cholesterol-fed rabbits, IV: investigation of macrophage-like properties of aortic cell populations. Lab Invest 41:372-378. (Pubitemid 10241353)
19. Fuhrman B, Volkova N, Aviram M. (2002) Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. Atherosclarosis161:307-316. (Pubitemid 34219183)
20. 31Gaidukov L, Tawfik D (2005) High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Biochemistry. 44:11843-11854. (Pubitemid 41262719)
21. Gerrity RG (1981) The role of the monocyte in atherogenesis, II: migration of foam cells from atherosclerotic lesions. Am J Pathol 103:191-200 (Pubitemid 11112974)
22. Harel M, Aharoni A, Gaidukov L et al. (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11:412-419. (Pubitemid 38568944)
23. Heidenreich S(1999). Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides. J Leukoc Biol 65:737-743 (Pubitemid 29279520)
24. Heinecke J (1997) Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipido. 18:268-274 (Pubitemid 27462433)
25. Huber SA, Sakkinen P, Conze D et al. (1999) Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19:2364-2367 (Pubitemid 29477837)
26. Idem M (1976) The pathogenesis of atherosclerosis. N Engl J Med 295:369-377, 420-425.
27. James, R, Blatter Garin M, Calabresi L et al. (1998) Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states. Atherosclerosis. 139:77-82 (Pubitemid 28341869)
28. James R, Deakin S (2004) The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radic Biol Med 37:1986-1994 (Pubitemid 39491318)
29. Jian B, de la Llera-Moya M, Royer L et al. (1997) Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J Lipid Res 38:734-744 (Pubitemid 27194924)
30. Kakafika AI, Xenofontos S, Tsimihodimos V (2003) The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity. J Lipid Res 44:1919-1926. (Pubitemid 37356664)
31. Kiener PA, Davies PM, Starling GC et al. (1997) Differential induction of apoptosis by Fas-Fas ligand interaction in human monocytes and macrophages. J Exp Med 185:1511-1516 (Pubitemid 27187609)
32. Kisilevsky R, Subrahmanyan L (1992) Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 66: 778-785
33. Krieger M (1998) The "best" of cholesterols, the "worst" of cholesterols: a tale of two receptors. Proc Natl Acad Sci USA 14:4077-4080. (Pubitemid 28207864)
34. Kudchodkar B, Lacko A, Dory L, Fungwe T (2000) Dietary fat modulates serum paraoxonase 1 activity in rats. Nutr 130:2427-2433
35. La Du B, Adkins S, Kuo C et al. (1993) Studies on human serum paraoxonase/ arylesterase. Chem Biol Interact 87:25-34. (Pubitemid 23205359)
36. Liu Y, Hulten LM, Wiklund O (1997) Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol 17:317-323 (Pubitemid 27098190)
37. Mackness M, Boullier H, Hennuyer M et al. (2000) Paraoxonase activity is reduced by a proatherogenic diet in rabbits. Biochem Biophys Res Commun 269:232-236.
38. Mackness B, Davies G, Turkie W et al. (2001) Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 211:451-457
39. Mackness B, Hunt R, Durrington PN (1997) Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis. Arterioscler Thromb Vasc Biol 17:1233-1238. (Pubitemid 27329844)
40. Mackness M, Mackness B, Durrington P et al. (1996) Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7:69-76. (Pubitemid 26167018)
41. Nakata A, Nakagawa Y, Nishida M et al. (1999) CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipidladen macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol 19:1333-1339. (Pubitemid 29227655)
42. Napoli C, D'Armiento F, Mancini F et al. (1997) Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 100:2680-2690. (Pubitemid 28007535)
43. National Cholesterol Education Program. (1993) Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
44. Bethesda, Md. : National Heart, Lung, and Blood Institute. (NIH publication no. 93-3095.)
45. Navab M, Ananthramaiah GM, Reddy ST et al. (2004) The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45: 993-1007 (Pubitemid 38679495)
46. Nguyen S, Sok D(2003) Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization. Biochem J 15375:275-285. (Pubitemid 37315435)
47. Nguyen SD, Sok DE (2006) Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position. Biochim Biophys Acta 1758:499-508. (Pubitemid 43786451)
48. Nicholls SJ et al. (2005) Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 111: 1543-1550 (Pubitemid 40470651)
49. Oda, M, Bielicki J, Berger T et al. (2002) Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity. Biochemistry 40:1710-1718 (Pubitemid 32144041)
50. Pinderski Oslund L, Hedrick C, Hagenbaugh A et al. (1999) Interleukin-10 blocks atherosclerosis events in vivo and in vitro. Arterioscler Thromb Vasc Biol 19:2847-2853 (Pubitemid 30029809)
51. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN (1996) The human serum paraoxonase/ arylesterase gene (PON1) is one member of a multigene family. Genomics 33:498-507. (Pubitemid 26159866)
52. Rao C, Zang E, Reddy B (1993) Effect of high fat corn oil, olive oil and fish oil on phospholipid fatty acid composition in male F344 rats. Lipids 28:441-447 (Pubitemid 23143827)
53. Rodrigo L, Hernandez A, Lopez-Caballero J (2001) Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem Biol Interact 137:123-137. (Pubitemid 32825504)
54. Rosenblat M, Vaya J, Shih D et al. (2005) Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Atherosclarosis. 179:69-77. (Pubitemid 40249787)
55. Ross R (1986) The pathogenesis of atherosclerosis-an update. N Engl J Med 314:488-500.
56. Ross R (1993) Atherosclerosis: defense mechanisms gone awry. Am J Pathol 143:987-1002 (Pubitemid 24070539)
57. Ross R, Glomset J (1973) Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180: 1332-1339.
58. Rozenberg O, Shih DM, Aviram M (2003) Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2- like activity and lysophosphatidylcholine formation. Arterioscler Thromb Vasc Biol 23:461-467. (Pubitemid 36337223)
59. Ruiz-Gutierrez V, Molina M, Vazquez C (1990) Comparative effects of feeding different fats on fatty acid composition of major individual phospholipids of rat hearts. Ann Nutr Metab 34: 350-358 (Pubitemid 20377489)
60. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389.
61. Schaffner T, Taylor K, Bartucci E et al. (1980) Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am J Pathol 100:57-80.
62. Schmitz G, Robenek H, Lohmann U, Assmann G(1985) Interaction of HDLs with cholesteryl esterladen macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of HDLs by macrophages. EMBO J 4:613-622.
63. Schmitz G, Schambeck C (2006) Molecular defects in the ABCA1 pathway affect platelet function. Pathophysiol Haemost Thromb 35:166-174.
64. Shih D, Gu L, Xia Y et al (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284-287. (Pubitemid 28335041)
65. Shih D, Xia Y, Miller E et al. (2001) Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J. Biol. Chem 275:7527-17535
66. Shiner M, Fuhrman B, Aviram M(2007) Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Biol Chem 388:1353-1358. (Pubitemid 350135567)
67. Silva E, Kong M, Han Z (1999) Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. J Lipid Res 40:1211-1221. (Pubitemid 29328524)
68. Small DM (1992) Plasma lipoprotein and coronary artery disease, (Kreisberg R. A, Segrest J. P (eds. ), 1st ed. , Boston: Blackwell scientific publications, chapter 3, 57-84
69. Sola R, Motta C, Maille M et al. (1993) Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb 13:958-966. (Pubitemid 23195796)
70. Sorenson RC, Bisgaier CL, Aviram M (1999) Human serum paraoxonase/ arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids; apolipoprotein A 1 stabilizes activity. Arterioscler Thromb Vasc Biol 19:2214-2225. (Pubitemid 29422255)
71. Stary H, Chandler A, Glagov S (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89:2462-2478. (Pubitemid 24142837)
72. Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963-20966. (Pubitemid 27373946)
73. Takahashi K (2001) Development and differentiation of macrophages and related cells: historic review and current concepts. J Clin Exp Hematopathol 41:1-32
74. Tavori H, Aviram, M, Khatib S et al. (2008) Human carotid atherosclerotic plaque increases oxidative stress of macrophages and LDL, whereas Paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med [In Review]
75. Tavori H, Khatib S, Aviram M, et al. (2008) Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity. Bioorg Med Chem 16:7504-7509.
76. Tward A, Xia Y, Wang X, (2002) Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106:484-490 (Pubitemid 34803695)
77. van Furth R. (1989) Origin and turnover of monocytes and macrophages. In: Iverson O (ed) Cell kinetics of inflammatory reaction. Berlin: Springer 125-150
78. Witztum J, Steinberg, D (1991) Role of oxidized low density lipoprotein in atherogenesis Clin Invest 88:1785-1792.
79. Yaqoob P, Sherrington E, Jeffery N et al. (1995) Comparison of the effects of a range of dietary lipids upon serum and tissue lipid composition in the rat. Int J Biochem Cell Biol 27:297-310